GAS5 and type 2 diabetes mellitus: Additionally, the circulating levels of lncRNA growth-arrest-specific 5 (GAS5) have been found to be reduced both in diabetic patients as well as in a type 2 diabetic mouse model, suggesting an involvement of this lncRNA in the pathogenesis of this disease [262,263].